XML 48 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Total revenues $ 622.1 $ 498.8 $ 1,727.6 $ 1,371.9
Operating expenses:        
Cost of revenues 8.0 11.2 24.7 31.2
Research and development 195.0 142.2 545.5 427.5
Acquired in-process research and development 1.0 0.0 9.5 143.9
Selling, general, and administrative 234.3 204.2 719.4 668.7
Total operating expenses 438.3 357.6 1,299.1 1,271.3
Operating income 183.8 141.2 428.5 100.6
Other income (expense):        
Unrealized loss on equity investments (16.9) (40.1) (35.2) (0.6)
Charges associated with convertible senior notes 0.0 0.0 (138.4) 0.0
Investment income and other, net 23.4 14.5 68.5 33.9
Total other income (expense), net 6.5 (25.6) (105.1) 33.3
Income before provision for income taxes 190.3 115.6 323.4 133.9
Provision for income taxes 60.5 32.5 85.2 31.9
Net income 129.8 83.1 238.2 102.0
Foreign currency translation adjustments, net of tax 2.9 (1.4) 2.5 0.7
Unrealized gain on available-for-sale debt securities, net of tax 9.1 0.8 5.0 5.5
Comprehensive income $ 141.8 $ 82.5 $ 245.7 $ 108.2
Earnings per share:        
Basic (in USD per share) $ 1.28 $ 0.85 $ 2.37 $ 1.05
Diluted (in USD per share) $ 1.24 $ 0.82 $ 2.29 $ 1.01
Weighted-average shares outstanding:        
Basic (in shares) 101.1 97.9 100.6 97.5
Diluted (in shares) 104.3 101.1 104.0 100.6
Net product sales        
Revenues:        
Total revenues $ 616.6 $ 491.8 $ 1,709.4 $ 1,353.4
Collaboration revenues        
Revenues:        
Total revenues $ 5.5 $ 7.0 $ 18.2 $ 18.5